Moscow screening: breast cancer screening with mammography as a method of improving early stage cancer detection

Morozov, S. P.; Морозов, С. П.; Ветшева, Н Н; Ovsyannikov, A. G.; Овсянников, А Г; Ledihova, N. V.; Ledikhova, Natalia; Панина, Е В; Polishchuk, Nikita S.; Пучкова, О. С.

doi:10.32687/0869-866x-2019-27-si1-623-629

Cited by 4 publications

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Несмотря на ряд спорных вопросов, большинство экспертов поддерживают программы скрининга на РМЖ, при этом подчеркивается, что женщины, приглашаемые на скрининг, должны в обязательном порядке быть информированы о вероятности как пользы, так и вреда их здоровью. Приступили к массовому обследованию женщин на РМЖ и в Москве в рамках территориальной программы обязательного медицинского страхования [18]. Следует отметить, что в настоящее время в России нормативными документами предусмотрены скрининг на рак шейки матки, РМЖ, рак предстательной железы, рак толстого кишечника и прямой кишки, пищевода, желудка и двенадцатиперстной кишки, а также выявление визуальных и иных локализаций онкологических заболеваний; исследования на выявление рака легких [19].…”

Section: Discussionunclassified

Malignant neoplasms mortality rates in Moscow and Saint Petersburg in 2015 and 2018

Samorodskaya¹,

Самородская²,

Semenov

et al. 2020

J. Mod. Onco.

View full text Add to dashboard Cite

Significant differences in mortality rates of the most of the death causes were detected between Moscow and Saint-Petersburg in the number of researches. Aim.Comparison and ranging of standardized mortality rates (SMR) from malignant neoplasms (MN) of different localizations in Moscow and in Saint-Petersburg in 2015 and 2018; determination of the localizations with main input in SMR from MN. Materials.Number of citizens and number of deaths from tumors accordingly to Rosstat Short nomenclature of the death reasons were evaluated. Death rates were calculated using the special computer programs on the base of European standard, comparison was provided with help of non-parametric criteria. Results.SMR of 29 from 33 MN localizations became lower in 2018 comparing to 2015 both in Moscow and in Saint-Petersburg. The average SMR decreased in 2018 in Saint-Petersburg statistically significant (p=0.003) and in Moscow non-significant (p=0.34). The largest SMR value both in 2015 and in 2018 in Moscow and in Saint-Petersburg as well were registered from 7 cancer localizations (trachea, bronchus, lungs; large intestine; breast; pancreas; rectum; prostate). The share of these SMR localizations in all MN was 57% and 54% in Moscow and 57 and 56% in Saint-Petersburg correspondingly. SMR of all 7 localizations were lower in Moscow comparing to Saint-Petersburg. SMR was lower in 2018 comparing to 2015 in both cities. The share of MN of others, unspecified, non-classified, etc. localizations in all MN was 11% in 2015 in both cities. Its share was in 2018 13.5% in Moscow and 10.1% in Saint Petersburg. Conclusions.SMR of most MN was higher in Saint Petersburg as in Moscow both in 2015 and in 2018. The analyses of the effectiveness of screening programs and of health care organization for patients with MN with highest SMR is needed. The questions of the differential diagnostics (intravital and postmortem) and of control the quality of medical death certificates filling in should be solved for the decrease of mortality of nonrefinement MN.

show abstract

Section: Discussionunclassified

Malignant neoplasms mortality rates in Moscow and Saint Petersburg in 2015 and 2018

Samorodskaya¹,

Самородская²,

Semenov

et al. 2020

J. Mod. Onco.

View full text Add to dashboard Cite

show abstract

The use of computer vision for the mammography preventive research

Arzamasov¹,

Vladzymyrskyy²,

Omelyanskaya³

et al. 2023

Profil. med.

View full text Add to dashboard Cite

The dynamics of the incidence of breast cancer in the Moscow region (2011–2018)

2020

View full text Add to dashboard Cite

Introduction. Breast cancer is a serious medical and social challenge and the statistics around the world look daunting.Relevance. The incidence of breast cancer is increasing in most countries and this may be due to a number of reasons. First of all, it should be noted the improvement of diagnostic methods, in particular, mass mammographic screening, which allows detecting neoplasms at early stages, before the onset of clinical symptoms. As for mortality rates, in recent years, world statistics show a downward trend in rates.Goal. To analyze the incidence and mortality rates of breast cancer (BC) in the Moscow Region (MO) for the period from 2011 to 2018. The study of indicators in one of the regions of Russia – MO – is of great importance for determining and predicting the true needs of the population in specialized medical care.The purpose of the study was to analyze the incidence of breast cancer (breast cancer) in the Moscow Region (MO) for a period of time from 2011 to 2018.Materials and methods. Some data of the territorial cancer registry of the Ministry of Defense of the Russian Federation on the diagnosis and treatment of patients with breast cancer were used, which will make it possible to determine the needs of this cohort of patients in specialized care.Results. From 2011 to 2018, 26755 new cases of breast cancer were diagnosed in the Moscow Region. The analysis of the comparative stratification in breast cancer in the medical district made it possible to obtain statistically significant differences indicating an increase in the incidence in the period from 2015–2018 in comparison with the period of 2011–2014. The presented data also indicate a trend towards a decrease in the one-year mortality rate over 8 years: from 6.33% in 2011 to 5.32% in 2018. For the period from 2011 to 2018 (8 years) there is an increase in the number of patients with breast cancer who have been in the medical center under dispensary supervision for 5 years or more.Conclusions. Analysis of the data obtained on the indicators of morbidity and mortality from malignant neoplasms is of great importance for determining the needs of the population in specialized medical care.

show abstract

Moscow screening: breast cancer screening with mammography as a method of improving early stage cancer detection

Cited by 4 publications

References 0 publications

Malignant neoplasms mortality rates in Moscow and Saint Petersburg in 2015 and 2018

Malignant neoplasms mortality rates in Moscow and Saint Petersburg in 2015 and 2018

The use of computer vision for the mammography preventive research

The dynamics of the incidence of breast cancer in the Moscow region (2011–2018)

Contact Info

Product

Resources

About